The consumer incentives encourage biological advances nearly ideally. Even diseases from which the West no longer suffers have incentives as NGOs and other organizations will pay billions for effective cures. The difficulty is that the FDA makes productive research very expensive and difficult to quickly iterate based on real feedback, and the academic publishing system is full of questionable research that slows down the advance of honest research as it is not reliable.